Ilgesin

Naproxen sodium, the active ingredient in Ilgesin, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is used to relieve mild to moderate pain, reduce inflammation, and lower fever in adults, and is indicated for conditions such as osteoarthritis, rheumatoid arthritis, and dysmenorrhea.

GNH USA supplies Ilgesin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets.

Ilgesin (naproxen sodium) is an NSAID that targets inflammatory pathways to manage various pain‑related conditions.

Mild to moderate pain: provides analgesic relief for acute or chronic discomfort. Inflammation: reduces swelling and redness associated with musculoskeletal disorders. Fever: lowers elevated body temperature in febrile states. Osteoarthritis: improves joint function and decreases pain in degenerative joint disease. Rheumatoid arthritis: helps control inflammatory activity and joint pain. Dysmenorrhea: alleviates menstrual‑related cramping and discomfort.

Like other NSAIDs, naproxen sodium may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Gastrointestinal upset (nausea, dyspepsia, abdominal pain) - Headache - Dizziness - Mild skin rash or itching

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation - Cardiovascular events such as myocardial infarction or stroke - Severe skin reactions (Stevens‑Johnson syndrome, toxic epidermal necrolysis) - Acute renal impairment or failure

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for potential complications. - Assess renal function: avoid or adjust use in patients with significant kidney impairment. - Evaluate cardiovascular risk: use cautiously in individuals with a history of heart disease or stroke. - Review gastrointestinal history: consider gastro‑protective agents for patients with prior ulcers. - Monitor for hypersensitivity: discontinue if severe allergic reactions develop. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Naproxen sodium can interact with several drug classes, influencing safety or efficacy.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective serotonin reuptake inhibitors (SSRIs): heightened hemorrhage potential. - Lithium: naproxen may raise lithium serum concentrations.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function when combined. - Diuretics: may exacerbate renal impairment. - Methotrexate: naproxen can decrease methotrexate clearance, raising toxicity risk.